Testicular Cancer, An Issue of Urologic ClinicsElsevier Health Sciences, 29 lip 2015 - 159 This issue provides much needed updates since Dr. Sheinfeld's issue published in 2007. Dr. Lin has assembled expert authors to provide clinicians with the full breadth of clinical updates on testicular cancer. New to this issue are articles on clinical outcomes, survivorship, and several articles on the management of Nonseminomatous Germ Cell Tumors. |
Spis treści
Urologic Clinics Of North America
| xiii |
Foreword
| 265 |
Preface | 267 |
Epidemiology and Diagnosis of Testis Cancer | 269 |
Intratubular Germ Cell Neoplasia of the Testis Bilateral Testicular Cancer and Aberrant Histologies | 277 |
Management of LowStage Testicular Seminoma | 287 |
Management of Stage I Nonseminomatous Germ Cell Tumors | 299 |
The Evolution and Technique of NerveSparing Retroperitoneal Lymphadenectomy | 311 |
Desperation Postchemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Germ Cell Tumors | 343 |
Chemotherapy for GoodRisk Nonseminomatous Germ Cell Tumors | 347 |
Late Relapse of Testicular Germ Cell Tumors | 359 |
Role of Extraretroperitoneal Surgery in Patients with Metastatic Germ Cell Tumors | 369 |
Reoperative Retroperitoneal Surgery | 381 |
Longterm Morbidity of Testicular Cancer Treatment | 393 |
Infertility with Testicular Cancer | 409 |
| 421 | |
Minimally Invasive Retroperitoneal Lymphadenectomy | 321 |
The Role of Postchemotherapy Surgery in Germ Cell Tumors | 331 |
Inne wydania - Wyświetl wszystko
Kluczowe wyrazy i wyrażenia
adjuvant Ann Oncol associated bilateral bleomycin carboplatin carcinoma chemo chylous ascites cisplatin Clin Oncol clinical stage contralateral CSI NSGCT cycles of BEP disease dose ejaculation etoposide evaluated Fossa SD germ cell cancer germ cell testicular germ cell tumors guidelines histology hypogonadism increased risk infertility ITGCN laparoscopic late relapse Leydig cell long-term lymph node dissection lymphadenectomy malignant median follow-up metastatic modified template morbidity NCCN necrosis nerve sparing nerve-sparing nonseminomatous germ cell Oncology orchiectomy ototoxicity outcomes patients with testicular PC-RPLND prognostic pulmonary radiation radiotherapy rates recurrence regimens renal reported resection residual masses retroperitoneal lymph node retroperitoneal lymphadenectomy retroperitoneum risk factors RPLND seminoma serum tumor markers sperm stage I nonseminomatous stage I seminoma stage I testicular surgical survival survivors teratoma testicular cancer testicular germ cell testicular tumors testis cancer TGCTs therapy tients tion toxicity treatment tumor markers unilateral template Urology viable GCT vinblastine